81 FR 38218 - Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection-Import/Export Declaration for List I and List II Chemicals, DEA Forms 486, 486A
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 113 (June 13, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 113 (June 13, 2016)
| Page Range | 38218-38219 | |
| FR Document | 2016-13908 |
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)] [Notices] [Pages 38218-38219] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-13908] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117-0023] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection--Import/Export Declaration for List I and List II Chemicals, DEA Forms 486, 486A AGENCY: Drug Enforcement Administration, Department of Justice ACTION: 60-Day notice. ----------------------------------------------------------------------- SUMMARY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until August 12, 2016. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Clifton A. Coward, Jr., Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598-6812. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: --Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; --Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; --Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and --Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Import/Export Declaration for List I and List II Chemicals. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 486, 486A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. [[Page 38219]] Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: Section 1018 of the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 971) and Title 21 Code of Federal Regulations (21 CFR) Part 1313 require any persons who import, export, or conduct international transactions involving list I and list II chemicals are required to establish a system of recordkeeping and report certain information regarding those transactions to the DEA. The chemicals subject to control are used in the clandestine manufacture of controlled substances. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The below table presents information regarding the number of respondents, responses and associated burden hours. ---------------------------------------------------------------------------------------------------------------- Number of Number of Average time annual annual per response Total annual respondents * responses (minutes) hours ---------------------------------------------------------------------------------------------------------------- DEA-486--Import (paper)......................... 342 1,359 17 385 DEA-486--Import (online)........................ .............. 855 17 242 DEA-486--Export (paper)......................... .............. 2,533 20 844 DEA-486--Export (online)........................ .............. 7,743 20 2,581 DEA-486--International (paper).................. .............. 422 17 120 DEA-486A--Import (paper)........................ .............. 333 20 111 DEA-486A--Import (online)....................... .............. 416 20 139 --------------------------------------------------------------- Total....................................... 342 13,661 .............. 4,422 ---------------------------------------------------------------------------------------------------------------- 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates that this collection takes 4,442 annual burden hours. If additional information is required please contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 20530. Dated: June 8, 2016. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2016-13908 Filed 6-10-16; 8:45 am] BILLING CODE 4410-09-P
![38218 Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Controlled substance Schedule
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I
Dimethyltryptamine (7435) .......................................................................................................................................................................... I
Psilocybin (7437) ......................................................................................................................................................................................... I
5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I
N-Benzylpiperazine (7493) .......................................................................................................................................................................... I
MDPV (3,4-Methylenedioxypyrovalerone) (7535) ....................................................................................................................................... I
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) ....................................................................................................................... I
Heroin (9200) ............................................................................................................................................................................................... I
Normorphine (9313) .................................................................................................................................................................................... I
Norlevorphanol (9634) ................................................................................................................................................................................. I
Amphetamine (1100) ................................................................................................................................................................................... II
Methamphetamine (1105) ........................................................................................................................................................................... II
Nabilone (7379) ........................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
Cocaine (9041) ............................................................................................................................................................................................ II
Codeine (9050) ............................................................................................................................................................................................ II
Ecgonine (9180) .......................................................................................................................................................................................... II
Levomethorphan (9210) .............................................................................................................................................................................. II
Levorphanol (9220) ..................................................................................................................................................................................... II
Meperidine (9230) ....................................................................................................................................................................................... II
Metazocine (9240) ....................................................................................................................................................................................... II
Methadone (9250) ....................................................................................................................................................................................... II
Morphine (9300) .......................................................................................................................................................................................... II
Thebaine (9333) .......................................................................................................................................................................................... II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Remifentanil (9739) ..................................................................................................................................................................................... II
Sufentanil (9740) ......................................................................................................................................................................................... II
Carfentanil (9743) ........................................................................................................................................................................................ II
Fentanyl (9801) ........................................................................................................................................................................................... II
The company plans to manufacture DATES: Comments are encouraged and —Evaluate whether and if so how the
reference standards. will be accepted for 60 days until quality, utility, and clarity of the
Dated: June 7, 2016. August 12, 2016. information proposed to be collected
Louis J. Milione, FOR FURTHER INFORMATION CONTACT: If can be enhanced; and
you have comments on the estimated —Minimize the burden of the collection
Deputy Assistant Administrator.
public burden or associated response of information on those who are to
[FR Doc. 2016–13914 Filed 6–10–16; 8:45 am]
time, suggestions, or need a copy of the respond, including through the use of
BILLING CODE 4410–09–P
proposed information collection appropriate automated, electronic,
instrument with instructions or mechanical, or other forms of
additional information, please contact information technology, e.g.,
DEPARTMENT OF JUSTICE
Clifton A. Coward, Jr., Office of permitting electronic submission of
Drug Enforcement Administration Diversion Control, Drug Enforcement responses.
Administration; Mailing Address: 8701 Overview of This Information
[OMB Number 1117–0023]
Morrissette Drive, Springfield, Virginia Collection
Agency Information Collection 22152; Telephone: (202) 598–6812.
1. Type of Information Collection:
Activities; Proposed eCollection, SUPPLEMENTARY INFORMATION: Written Extension of a currently approved
eComments Requested; Extension comments and suggestions from the collection.
Without Change of a Previously public and affected agencies concerning 2. Title of the Form/Collection:
Approved Collection—Import/Export the proposed collection of information Import/Export Declaration for List I and
Declaration for List I and List II are encouraged. Your comments should List II Chemicals.
Chemicals, DEA Forms 486, 486A address one or more of the following
3. The agency form number, if any,
four points:
AGENCY: Drug Enforcement and the applicable component of the
Administration, Department of Justice —Evaluate whether the proposed Department sponsoring the collection:
ACTION: 60-Day notice.
collection of information is necessary DEA Forms: 486, 486A. The applicable
for the proper performance of the component within the Department of
SUMMARY: The Department of Justice functions of the agency, including Justice is the Drug Enforcement
srobinson on DSK5SPTVN1PROD with NOTICES
(DOJ), Drug Enforcement whether the information will have Administration, Office of Diversion
Administration (DEA), will be practical utility; Control.
submitting the following information —Evaluate the accuracy of the agency’s 4. Affected public who will be asked
collection request to the Office of estimate of the burden of the or required to respond, as well as a brief
Management and Budget (OMB) for proposed collection of information, abstract:
review and approval in accordance with including the validity of the Affected public (Primary): Business or
the Paperwork Reduction Act of 1995. methodology and assumptions used; other for-profit.
VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1](https://thefederalregister.org/doc/81_FR_38331/page/1.svg)
![Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices 38219
Affected public (Other): Not-for-profit transactions involving list I and list II 5. An estimate of the total number of
institutions; Federal, State, local, and chemicals are required to establish a respondents and the amount of time
tribal governments. system of recordkeeping and report estimated for an average respondent to
Abstract: Section 1018 of the certain information regarding those respond: The below table presents
Controlled Substances Import and transactions to the DEA. The chemicals information regarding the number of
Export Act (CSIEA) (21 U.S.C. 971) and subject to control are used in the respondents, responses and associated
Title 21 Code of Federal Regulations (21 clandestine manufacture of controlled burden hours.
CFR) Part 1313 require any persons who substances.
import, export, or conduct international
Average
Number of Number of time per Total annual
annual annual response hours
respondents * responses (minutes)
DEA–486—Import (paper) ............................................................................... 342 1,359 17 385
DEA–486—Import (online) ............................................................................... ........................ 855 17 242
DEA–486—Export (paper) ............................................................................... ........................ 2,533 20 844
DEA–486—Export (online) .............................................................................. ........................ 7,743 20 2,581
DEA–486—International (paper) ..................................................................... ........................ 422 17 120
DEA–486A—Import (paper) ............................................................................. ........................ 333 20 111
DEA–486A—Import (online) ............................................................................ ........................ 416 20 139
Total .......................................................................................................... 342 13,661 ........................ 4,422
6. An estimate of the total public review and approval in accordance with information technology, e.g.,
burden (in hours) associated with the the Paperwork Reduction Act of 1995. permitting electronic submission of
proposed collection: The DEA estimates DATES: Comments are encouraged and responses.
that this collection takes 4,442 annual will be accepted for 60 days until Overview of This Information
burden hours. August 12, 2016. Collection
If additional information is required FOR FURTHER INFORMATION CONTACT: If
please contact: Jerri Murray, you have comments on the estimated 1. Type of Information Collection:
Department Clearance Officer, United public burden or associated response Extension of a currently approved
States Department of Justice, Justice time, suggestions, or need a copy of the collection.
Management Division, Policy and proposed information collection 2. Title of the Form/Collection:
Planning Staff, Two Constitution instrument with instructions or Controlled Substances Import/Export
Square, 145 N Street NE., Suite 3E.405B, additional information, please contact Declaration (DEA Form 236).
Washington, DC 20530. Clifton A. Coward, Jr., Office of 3. The agency form number, if any,
Dated: June 8, 2016. Diversion Control, Drug Enforcement and the applicable component of the
Administration; Mailing Address: 8701 Department sponsoring the collection:
Jerri Murray,
Morrissette Drive, Springfield, Virginia Form Number: DEA Form 236. The
Department Clearance Officer for PRA, U.S.
22152; Telephone: (202) 598–6812. Department of Justice component is the
Department of Justice.
SUPPLEMENTARY INFORMATION: Written Drug Enforcement Administration,
[FR Doc. 2016–13908 Filed 6–10–16; 8:45 am]
comments and suggestions from the Office of Diversion Control.
BILLING CODE 4410–09–P
public and affected agencies concerning 4. Affected public who will be asked
the proposed collection of information or required to respond, as well as a brief
are encouraged. Your comments should abstract:
DEPARTMENT OF JUSTICE
address one or more of the following Affected public (Primary): Business or
Drug Enforcement Administration four points: other for-profit.
—Evaluate whether the proposed Affected public (Other): None.
[OMB Number 1117–0009] Abstract: DEA Form 236 enables the
collection of information is necessary
for the proper performance of the DEA to monitor and control the
Agency Information Collection importation and exportation of
Activities; Proposed eCollection, functions of the agency, including
whether the information will have controlled substances. Analysis of these
eComments Requested; Extension documents provides the DEA with
Without Change of a Previously practical utility;
—Evaluate the accuracy of the agency’s important intelligence regarding the
Approved Collection Controlled international commerce in controlled
Substances Import/Export Declaration estimate of the burden of the
proposed collection of information, substances and assists in the
DEA Form 236 identification of suspected points of
including the validity of the
AGENCY: Drug Enforcement methodology and assumptions used; diversion.
Administration, Department of Justice —Evaluate whether and if so how the 5. An estimate of the total number of
respondents and the amount of time
srobinson on DSK5SPTVN1PROD with NOTICES
ACTION: 60-Day notice. quality, utility, and clarity of the
information proposed to be collected estimated for an average respondent to
SUMMARY: The Department of Justice can be enhanced; and respond: The DEA estimates that there
(DOJ), Drug Enforcement —Minimize the burden of the collection are 157 total respondents for this
Administration (DEA), will be of information on those who are to information collection. In total, 157
submitting the following information respond, including through the use of respondents submit 6,321 responses,
collection request to the Office of appropriate automated, electronic, with each response taking 17 minutes to
Management and Budget (OMB) for mechanical, or other forms of complete.
VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1](https://thefederalregister.org/doc/81_FR_38331/page/2.svg)
Document Created: 2018-02-08 07:39:43
Document Modified: 2018-02-08 07:39:43
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | 60-Day notice. | |
| Dates | Comments are encouraged and will be accepted for 60 days until August 12, 2016. | |
| Contact | If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Clifton A. Coward, Jr., Office | |
| FR Citation | 81 FR 38218 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR